Advances in the treatment of rheumatic diseases.
D000082:Acetaminophen / Q000627:therapeutic use; D000477:Alkylating Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000628:therapy; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D006276:Health Facility Size; D006801:Humans; D007165:Immunosuppression Therapy; D010396:Penicillamine / Q000627:therapeutic use; D010810:Physical and Rehabilitation Medicine; D012046:Rehabilitation; D012216:Rheumatic Diseases / Q000534:rehabilitation / Q000601:surgery / Q000628:therapy*; D013608:Tablets, Enteric-Coated
D000477:Alkylating Agents; D000893:Anti-Inflammatory Agents; D000963:Antimetabolites; D013608:Tablets, Enteric-Coated; D000082:Acetaminophen; D010396:Penicillamine; D001241:Aspirin